Profile data is unavailable for this security.
About the company
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
- Revenue in USD (TTM)15.48bn
- Net income in USD1.12bn
- Incorporated2022
- Employees21.78k
- LocationKenvue Inc199 Grandview RoadSKILLMAN 08558United StatesUSA
- Phone+1 (732) 524-0400
- Fax+1 (302) 655-5049
- Websitehttps://www.kenvue.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clorox Co | 7.09bn | 280.00m | 20.25bn | 8.00k | 72.99 | 61.90 | 38.42 | 2.85 | 2.24 | 2.24 | 56.91 | 2.64 | 1.21 | 6.04 | 10.26 | 886,625.00 | 4.99 | 8.58 | 7.42 | 12.41 | 43.21 | 41.45 | 4.12 | 7.24 | 0.6258 | 11.58 | 0.8347 | 107.32 | -4.01 | 2.68 | 87.92 | -19.34 | 0.5759 | 4.56 |
| Church & Dwight Co., Inc. | 6.00bn | 802.40m | 25.12bn | 5.55k | 31.60 | 5.83 | 24.29 | 4.19 | 3.25 | 3.25 | 24.27 | 17.59 | 0.6945 | 5.02 | 11.44 | 1,080,793.00 | 9.29 | 9.01 | 10.70 | 11.10 | 45.46 | 43.99 | 13.38 | 13.23 | 0.981 | 11.61 | 0.3396 | 36.20 | 9.16 | 7.19 | 82.56 | 5.85 | 29.91 | -1.24 |
| Estee Lauder Companies Inc | 15.61bn | 390.00m | 31.57bn | 62.00k | 81.46 | 5.94 | 25.58 | 2.02 | 1.08 | 1.08 | 43.33 | 14.82 | 0.6923 | 1.72 | 9.82 | 251,758.10 | 1.81 | 7.29 | 2.53 | 10.39 | 71.66 | 74.09 | 2.62 | 9.27 | 1.01 | 7.43 | 0.5939 | 54.31 | -2.06 | 0.9843 | -61.23 | -26.27 | 4.32 | 9.59 |
| Kenvue Inc | 15.48bn | 1.12bn | 44.41bn | 21.78k | 39.79 | 4.36 | 25.58 | 2.87 | 0.5828 | 0.5828 | 8.06 | 5.31 | 0.5733 | 3.37 | 7.14 | 710,514.30 | 4.15 | -- | 5.24 | -- | 57.87 | -- | 7.23 | -- | 0.6791 | 6.98 | 0.4544 | -- | 3.30 | -- | -19.38 | -- | -- | -- |
| Kimberly-Clark Corp | 20.28bn | 2.29bn | 47.54bn | 41.00k | 20.89 | 41.87 | 16.76 | 2.34 | 6.76 | 6.76 | 59.91 | 3.37 | 1.17 | 6.40 | 8.69 | 494,634.20 | 12.04 | 11.22 | 20.11 | 19.23 | 36.20 | 33.76 | 10.29 | 9.72 | 0.5754 | 14.89 | 0.8618 | 75.55 | 1.27 | 2.02 | -8.79 | 2.93 | -2.67 | 3.43 |
| Colgate-Palmolive Company | 19.99bn | 2.84bn | 84.31bn | 34.00k | 29.99 | 685.42 | 23.39 | 4.22 | 3.44 | 3.44 | 24.21 | 0.1505 | 1.22 | 4.07 | 11.48 | 587,882.40 | 18.36 | 15.98 | 27.32 | 22.67 | 59.70 | 58.96 | 15.02 | 13.96 | 0.6961 | 18.06 | 0.9474 | 67.49 | 8.29 | 4.59 | 28.85 | -1.50 | 10.09 | 2.85 |
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Aug 2024 | 212.89m | 11.12% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 205.95m | 10.75% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 108.93m | 5.69% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 90.00m | 4.70% |
| Massachusetts Financial Services Co.as of 30 Jun 2024 | 79.86m | 4.17% |
| Wellington Management Co. LLPas of 30 Jun 2024 | 76.45m | 3.99% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 75.88m | 3.96% |
| Geode Capital Management LLCas of 30 Jun 2024 | 44.28m | 2.31% |
| Strategic Advisers LLCas of 30 Jun 2024 | 37.00m | 1.93% |
| Managed Account Advisors LLCas of 30 Jun 2024 | 36.87m | 1.93% |
